Skip to main content
. 2021 Jun 10;6(9):2281–2291. doi: 10.1016/j.ekir.2021.05.027

Figure 1.

Figure 1

The design and main results of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease trial. CV, cardiovascular; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; HF, heart failure; MI, myocardial infarction; RAS, renin-angiotensin system; UACR, urinary albumin-to-creatinine ratio.